Skip to main content
ARVN
NASDAQ Life Sciences

Arvinas Posts 82-Cent Quarterly Loss as Profitability Fades

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$7.52
Mkt Cap
$491.704M
52W Low
$6.74
52W High
$14.51
52W Position info
12% above low
Off High info
48% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

ARVN is trading near its 52-week low of $6.74 (12% above the low).

Summary

Arvinas reported a third-quarter loss of 82 cents per share, a swing back into the red after Q2 2026's $169.4M net profit on $249.7M of revenue tied to the VEPPANU licensing deal and milestone payments. That prior profit was driven by one-time deal economics, so the quarterly loss is a reminder the underlying business still burns cash. Third-quarter revenue was USD 500 Thousand, and research and development expenses were $46.9M. With a market cap near $492M and shares at $7.52, the loss is material relative to the company's size and keeps the cash-runway question front and center. Arvinas reported $558.9M in cash, with runway into H2 2028.

At the time of this announcement, ARVN was trading at $7.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $491.7M. The 52-week trading range was $6.74 to $14.51. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ARVN - Latest Insights

ARVN
Nov 03, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.09
Real-time Price: $6.82 info
Change: -$0.270 (-4%) info
Market Cap: $448.572M info
ARVN
Nov 03, 2026, 8:09 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.06
Real-time Price: $6.82 info
Change: -$0.240 (-3%) info
Market Cap: $448.572M info
ARVN
Oct 07, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.52
Real-time Price: $6.82 info
Change: -$0.700 (-9%) info
Market Cap: $448.572M info
ARVN
Sep 28, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.60
Real-time Price: $6.82 info
Change: -$0.780 (-10%) info
Market Cap: $448.572M info
ARVN
Aug 04, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $9.00
Real-time Price: $6.82 info
Change: -$2.18 (-24%) info
Market Cap: $448.572M info